|
1
|
Di Stefano AL, Enciso-Mora V, Marie Y,
Desestret V, Labussière M, Boisselier B, Mokhtari K, Idbaih A,
Hoang-Xuan K, Delattre JY, et al: Association between glioma
susceptibility loci and tumour pathology defines specific molecular
etiologies. Neuro Oncol. 15:542–547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang C, Bao Z, Zhang W and Jiang T:
Progress on molecular biomarkers and classification of malignant
gliomas. Front Med. 7:150–156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu GY, Shi BZ and Li Y: FoxM1 regulates
Sirt1 expression in glioma cells. Eur Rev Med Pharmacol Sci.
18:205–211. 2014.PubMed/NCBI
|
|
5
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Johnson DR and Galanis E: Incorporation of
prognostic and predictive factors into glioma clinical trials. Curr
Oncol Rep. 15:56–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hou SX, Ding BJ, Li HZ, Wang L, Xia F, Du
F, Liu LJ, Liu YH, Liu XD, Jia JF, et al: Identification of
microRNA-205 as a potential prognostic indicator for human glioma.
J Clin Neurosci. 20:933–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan Y, Peng Y, Ou Y and Jiang Y:
MicroRNA-610 is downregulated in glioma cells, and inhibits
proliferation and motility by directly targeting MDM2. Mol Med Rep.
14:2657–2664. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo H, Nan Y, Zhen Y, Zhang Y, Guo L, Yu
K, Huang Q and Zhong Y: miRNA-451 inhibits glioma cell
proliferation and invasion by downregulating glucose transporter 1.
Tumour Biol. 37:13751–13761. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang G, Li Z, Tian N, Han L, Fu Y, Guo Z
and Tian Y: miR-148b-3p inhibits malignant biological behaviors of
human glioma cells induced by high HOTAIR expression. Oncol Lett.
12:879–886. 2016.PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pulikkan JA, Dengler V, Peramangalam PS,
Zada AA Peer, Müller-Tidow C, Bohlander SK, Tenen DG and Behre G:
Cell-cycle regulator E2F1 and microRNA-223 comprise an
autoregulatory negative feedback loop in acute myeloid leukemia.
Blood. 115:1768–1778. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Garzon R, Liu S, Fabbri M, Liu Z, Heaphy
CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, et al:
MicroRNA-29b induces global DNA hypomethylation and tumor
suppressor gene reexpression in acute myeloid leukemia by targeting
directly DNMT3A and 3B and indirectly DNMT1. Blood. 113:6411–6418.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johnnidis JB, Harris MH, Wheeler RT,
Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD and
Camargo FD: Regulation of progenitor cell proliferation and
granulocyte function by microRNA-223. Nature. 451:1125–1129. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dickstein J, Senyuk V, Premanand K,
Laricchia-Robbio L, Xu P, Cattaneo F, Fazzina R and Nucifora G:
Methylation and silencing of miRNA-124 by EVI1 and self-renewal
exhaustion of hematopoietic stem cells in murine myelodysplastic
syndrome. Proc Natl Acad Sci USA. 107:9783–9788. 2010; View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo S, Lu J, Schlanger R, Zhang H, Wang
JY, Fox MC, Purton LE, Fleming HH, Cobb B, Merkenschlager M, et al:
MicroRNA miR-125a controls hematopoietic stem cell number. Proc
Natl Acad Sci USA. 107:14229–14234. 2010; View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nana-Sinkam P and Croce CM: MicroRNAs in
diagnosis and prognosis in cancer: What does the future hold?
Pharmacogenomics. 11:667–669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Q, Guo W, Zhang Y, Wu Y and Xiang J:
miR-19a promotes cell proliferation and invasion by targeting RhoB
in human glioma cells. Neurosci Lett. 628:161–166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu Y, Zhao H, Feng L and Xu S:
MicroRNA-217 inhibits cell proliferation and invasion by targeting
Runx2 in human glioma. Am J Transl Res. 8:1482–1491.
2016.PubMed/NCBI
|
|
23
|
Duan J, Zhou K, Tang X, Duan J and Zhao L:
MicroRNA-34a inhibits cell proliferation and induces cell apoptosis
of glioma cells via targeting of Bcl-2. Mol Med Rep. 14:432–438.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li C, Liu Z, Yang K, Chen X, Zeng Y, Liu
J, Li Z and Liu Y: miR-133b inhibits glioma cell proliferation and
invasion by targeting Sirt1. Oncotarget. 7:36247–36254. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gu JJ, Zhang JH, Chen HJ and Wang SS:
MicroRNA-130b promotes cell proliferation and invasion by
inhibiting peroxisome proliferator-activated receptor-γ in human
glioma cells. Int J Mol Med. 37:1587–1593. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jinlong S, Lin F, Yonghui L, Li Y and
Weidong W: Identification of let-7a-2-3p or/and miR-188-5p as
prognostic biomarkers in cytogenetically normal acute myeloid
leukemia. PLoS One. 10:e01180992015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang H, Qi S, Zhang T, Wang A, Liu R, Guo
J, Wang Y and Xu Y: miR-188-5p inhibits tumour growth and
metastasis in prostate cancer by repressing LAPTM4B expression.
Oncotarget. 6:6092–6104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fang F, Chang RM, Yu L, Lei X, Xiao S,
Yang H and Yang LY: MicroRNA-188-5p suppresses tumor cell
proliferation and metastasis by directly targeting FGF5 in
hepatocellular carcinoma. J Hepatol. 63:874–885. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Garcia DM, Baek D, Shin C, Bell GW,
Grimson A and Bartel DP: Weak seed-pairing stability and high
target-site abundance decrease the proficiency of lsy-6 and other
microRNAs. Nat Struct Mol Biol. 18:1139–1146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu J, Lv Q, He J, Zhang H, Mei X, Cui K,
Huang N, Xie W, Xu N and Zhang Y: MicroRNA-188 suppresses G1/S
transition by targeting multiple cyclin/CDK complexes. Cell Commun
Signal. 12:662014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L and Liu H: microRNA-188 is
downregulated in oral squamous cell carcinoma and inhibits
proliferation and invasion by targeting SIX1. Tumour Biol.
37:4105–4113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mu Q, Wang L, Yu F, Gao H, Lei T, Li P,
Liu P, Zheng X, Hu X, Chen Y, et al: Imp2 regulates GBM progression
by activating IGF2/PI3K/Akt pathway. Cancer Biol Ther. 16:623–633.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shi L, Wang Z, Sun G, Wan Y, Guo J and Fu
X: miR-145 inhibits migration and invasion of glioma stem cells by
targeting ABCG2. Neuromolecular Med. 16:517–528. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kanzaki A, Kudo M, Ansai S, Peng WX,
Ishino K, Yamamoto T, Wada R, Fujii T, Teduka K, Kawahara K, et al:
Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for
distinguishing between cutaneous squamous cell carcinoma and
keratoacanthoma. Int J Oncol. 48:1007–1015. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ye S, Song W, Xu X, Zhao X and Yang L:
IGF2BP2 promotes colorectal cancer cell proliferation and survival
through interfering with RAF-1 degradation by miR-195. FEBS Lett.
590:1641–1650. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu W, Li Z, Xu W, Wang Q and Yang S:
Humoral autoimmune response to IGF2 mRNA-binding protein (IMP2/p62)
and its tissue-specific expression in colon cancer. Scand J
Immunol. 77:255–260. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Barghash A, Golob-Schwarzl N, Helms V,
Haybaeck J and Kessler SM: Elevated expression of the IGF2 mRNA
binding protein 2 (IGF2BP2/IMP2) is linked to short survival and
metastasis in esophageal adenocarcinoma. Oncotarget. 7:49743–49750.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu W, Li Y, Wang B, Dai L, Qian W and
Zhang JY: Autoimmune response to IGF2 mRNA-binding protein 2
(IMP2/p62) in breast cancer. Scand J Immunol. 81:502–507. 2015.
View Article : Google Scholar : PubMed/NCBI
|
